Bruker Corporation (BRKR) vs Insulet Corporation (PODD)
Bruker Corporation and Insulet Corporation are both Medical Devices companies. Bruker Corporation and Insulet Corporation are of similar size ($9.7B and $9.6B). Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Insulet Corporation trades at 25.4×. Insulet Corporation grew revenue faster over the last twelve months: 29.4% against 1.65%. Insulet Corporation has the higher net margin (12.3% vs −3.05%) and the higher return on invested capital (17.6% vs −0.47%). Across the 21 metrics below, Insulet Corporation leads on 19 and Bruker Corporation on 2.
Valuation
Profitability
| Metric | BRKR | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.42% | 71.07% | 56.01% |
| Operating margin | (0.87%) | 16.89% | (15.03%) |
| Net margin | (3.05%) | 12.29% | (20.40%) |
| Free cash flow margin | 2.68% | 8.70% | (7.24%) |
| Return on equity | (5.07%) | 26.02% | (15.32%) |
| Return on assets | (1.73%) | 11.31% | (19.72%) |
| Return on invested capital | (0.47%) | 17.56% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack